Barriers and Facilitators to HIV Testing Among Women
Journal Title: HIV/AIDS Research and Treatment – Open Journal - Year 2018, Vol 0, Issue 1
Abstract
Aim: The purpose of this secondary analysis was to analyze for barriers and facilitators to HIV testing in women attending community health clinics. Introduction: The Centers for Disease Control and Prevention (CDC), reported that all women account for 20% or 1 in 5 of new HIV cases (CDC, 2012). Of those new cases in heterosexual women, 5,300 were Black, 1,300 were White, and 1,200 were Hispanic/Latina. The CDC estimated that in 2012 there were 9,268 individuals living with a diagnosis of HIV or AIDS, of which 19% were women. Results: The existing de-identified data consisted of thirty individual interviews conducted using a semi-structured interview guide was collected as the initial phase of the parent study, “HIV Testing and Women’s Attitudes on HIV Vaccine Trials”. This secondary analysis addressed the identification of key obstacles to HIV testing and only those related portions of the transcripts were analyzed. The major themes identified were familiarity with testing, stigma, fear, perceived risks, and access to care. Conclusion: The themes implicated the need to further assess women for barriers and facilitators to testing, tailor community based interventions that have the ability to decrease fear and stigma, increase trust in testing methods and offer counseling to positive results.
Authors and Affiliations
Graham J. McDougall Jr.
Keywords
Related Articles
- EP ID EP560714
- DOI 10.17140/HARTOJ-SE-1-102
- Views 115
- Downloads 0
Determination on the Expression of Activated RANTES G 28 in HIV-1 Infection and in Co Infection with Hepatitis B Virus and Hepatitis C Virus and Its Effect on Leukocytes
Human Immunodeficiency Virus (HIV), coinfected with hepatitis B virus and hepatitis C virus challenges the immune system. Regulated on activation normal T cell expressed and secreted (RANTES) is one of the natural ligand...
Development of the M184V Mutation in HIV-1 Infection and Subsequent Treatment Outcomes
Objective: The purpose of this study was to describe the occurrence of the M184V mutation in a single clinic setting over a period of 10 years. We examined the combination Antiretroviral Therapy (cART) being taken at the...
Potential Therapy of HIV/AIDS and Ebola Outbreak with Pregnancy Hormone, Human Chorionic Gonadotropin
HIV is a retrovirus that destroys hosts’ immune system. AIDS is a late stage HIV infection. About 35 million people are living worldwide with HIV/AIDS, mostly in sub-Saharan Africa. Although there is no known cure, advan...
HIV/AIDS and Contraceptive Method Choice: Demographic and Socio-Economic Correlates of Contraceptive Method Choice Among HIV-Positive Women Practising Family Planning in Kenya
Introduction: As the generalized HIV epidemic in specific settings of sub-Saharan Africa continues to evolve, there is need for evidence-based response to address emerging challenges, which include enabling the large num...
Prevalence of Hepatitis B Virus among Blood Donors and Assessment of Blood Donor’s Knowledge about HBV in Sudan
The prevalence of Hepatitis B varies between different regions of Sudan according to several published reports, but no data is available about the prevalence of HBV in all Sudan states, in a given time. The objective of...